Mednet Logo
HomeEndocrinologyQuestion

Would you stop denosumab in a patient with chronic kidney disease if they develop asymptomatic hypocalcemia after the injection?

3
4 Answers
Mednet Member
Mednet Member
Endocrinology · University of Missouri School of Medicine

No. Stopping denosumab leads to rebound bone resorption and loss of all gains. The hypocalcemia indicates insufficient calcium and/or calcitriol. Calcium intake should be 1,000-1,200 mg daily from food and/or supplements in divided doses with food.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Rheumatology · Sunshine Rheumatology & Arthritis Center

No, please do not stop. Check Calcium levels 7 days after Denosumab injection and if asymptomatic hypocalcemia noted- increase calcium supplement to 2000 mg for 2-3 weeks.

Register or Sign In to see full answer

Mednet Member
Mednet Member
Nephrology · Rush Medical College

Full disclosure: I have not used it but everything I read about using it in CKD, at least in ESRD is that it can lead to profound extended hypocalcemia, so I wonder about it being started in the first place (to find that patient that has asymptomatic hypocalcemia). I suppose too what level of CKLD y...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Endocrinology · Brigham And Womens Hospital Endocrinology

Agree with not stopping and increasing calcium/calcitriol. Is reduced dose Prolia going to become more widely available, especially in this scenario?

Register or Sign In to see full answer

Would you stop denosumab in a patient with chronic kidney disease if they develop asymptomatic hypocalcemia after the injection? | Mednet